New ways to treat chronic kidney disease
Innovative therapeutic approaches to treat chronic kidney disease
This study is looking at how potassium affects people with chronic kidney disease (CKD) to find new ways to help manage the condition, which could lead to better dietary advice or treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10919186 on NIH RePORTER |
What this research studies
This research investigates the role of potassium in the progression of chronic kidney disease (CKD), which affects a significant portion of the population. The study focuses on understanding how potassium channels in the kidneys and skeletal muscle influence kidney injury and overall potassium balance in the body. By employing advanced techniques such as single cell RNA sequencing and electrophysiology, the research aims to identify potential therapeutic targets to slow down CKD progression. Patients may benefit from insights that could lead to new dietary recommendations or treatments based on potassium management.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with chronic kidney disease, particularly those experiencing potassium imbalances.
Not a fit: Patients with acute kidney injury or those without chronic kidney disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that slow the progression of chronic kidney disease and improve patient outcomes.
How similar studies have performed: Previous research has shown promising results in understanding the role of potassium in kidney function, suggesting that this approach could yield significant insights.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Terker, Andrew S. — Vanderbilt University Medical Center
- Study coordinator: Terker, Andrew S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.